Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease – is this type 3 diabetes?
about
Nutrition and the risk of Alzheimer's diseaseDirty electricity elevates blood sugar among electrically sensitive diabetics and may explain brittle diabetesBrain Insulin Resistance at the Crossroads of Metabolic and Cognitive Disorders in HumansInsulin: an emerging treatment for Alzheimer's disease dementia?Cerebral energy metabolism and the brain's functional network architecture: an integrative reviewCaenorhabditis elegans as a model organism to study APP functionImportance of pH homeostasis in metabolic health and diseases: crucial role of membrane proton transportDiabetes and Alzheimer disease, two overlapping pathologies with the same background: oxidative stressChronic adjunction of 1-deoxynojirimycin protects from age-related behavioral and biochemical changes in the SAMP8 mice.The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer's DiseaseLipid microdomain modification sustains neuronal viability in models of Alzheimer's diseaseG-protein-coupled receptor rhodopsin regulates the phosphorylation of retinal insulin receptorProtease-resistant glucose-dependent insulinotropic polypeptide agonists facilitate hippocampal LTP and reverse the impairment of LTP induced by beta-amyloidThe effects of induced type-I diabetes on developmental regulation of insulin & insulin like growth factor-1 (IGF-1) receptors in the cerebellum of rat neonatesMechanisms underlying insulin deficiency-induced acceleration of β-amyloidosis in a mouse model of Alzheimer's diseaseLong-term high-fat diet induces hippocampal microvascular insulin resistance and cognitive dysfunction.Related genes and potential biomarkers for early diagnosis of Alzheimer's disease: a preliminary study based on DNA microarray.O-GlcNAc cycling mutants modulate proteotoxicity in Caenorhabditis elegans models of human neurodegenerative diseases.Therapeutically relevant structural and functional mechanisms triggered by physical and cognitive exercise.Early limited nitrosamine exposures exacerbate high fat diet-mediated type 2 diabetes and neurodegeneration.Low density lipoprotein receptor-related protein 1 promotes anti-apoptotic signaling in neurons by activating Akt survival pathway.Association between risk factors for vascular dementia and adiponectin.Insulin Resistance as a Link between Amyloid-Beta and Tau Pathologies in Alzheimer's Disease.Alzheimer's disease is type 3 diabetes-evidence reviewed.Vascular and metabolic dysfunction in Alzheimer's disease: a review.Age-dependent modulation of synaptic plasticity and insulin mimetic effect of lipoic acid on a mouse model of Alzheimer's disease.Novel avenues of drug discovery and biomarkers for diabetes mellitus.Patients with rosacea have increased risk of dementia.Intranasal delivery of plasma and platelet growth factors using PRGF-Endoret system enhances neurogenesis in a mouse model of Alzheimer's disease.Obesity, insulin resistance, and Alzheimer's disease.New function of the adaptor protein SH2B1 in brain-derived neurotrophic factor-induced neurite outgrowthChanges in cerebrospinal fluid and blood plasma levels of IGF-II and its binding proteins in Alzheimer's disease: an observational study.The relationship between serum insulin-like growth factor I levels and ischemic stroke riskModulation of hippocampal neural plasticity by glucose-related signaling.Diabetes Mellitus, Cognitive Impairment, and Traditional Chinese Medicine.Neuronal DNA damage response-associated dysregulation of signalling pathways and cholesterol metabolism at the earliest stages of Alzheimer-type pathologyMechanisms of brain aging regulation by insulin: implications for neurodegeneration in late-onset Alzheimer's disease.Proteome-wide characterization of signalling interactions in the hippocampal CA4/DG subfield of patients with Alzheimer's disease.Amyloid-β oligomers induce differential gene expression in adult human brain slices.Unaltered Prion Pathogenesis in a Mouse Model of High-Fat Diet-Induced Insulin Resistance.
P2860
Q22241959-86DF3A08-EB91-402E-BFED-F9E200753B7CQ24658356-35CDE06D-D6D7-47EA-B2F6-D756D4424D99Q26739671-CBBA79BA-BBA2-44BD-BBA1-B5941AB93D0FQ26827376-9B6ED0F7-0A87-42B5-8E5C-316B68E99423Q26830365-5418A3CC-97FB-4C13-8FF6-D29239156EBEQ26851244-DC4D2E16-E721-4000-B6FB-F23A89AD9E35Q26995687-5EBF2A48-995A-4A8F-84AE-C4EAFA8B6AE3Q27022552-59017257-1353-4808-AA58-F6BBB6B8B173Q27313788-B53B8D7E-2E8D-4056-8318-A3391C0E889AQ28254943-4A064702-3CA0-498E-86C7-CB0DA0828BE6Q28278644-E536C424-707B-44CC-8881-EE2E810DD18DQ28507840-0ABED28C-C596-43CD-8F85-9FAB6310DDF4Q28565656-2D774B28-070D-49AF-BFB3-A444A440CC18Q28571907-2792588E-A3CE-4805-8B7F-9A0A1E9048E5Q28731520-11972E6C-DE09-4590-B941-8EBDC413697BQ30275335-9E94AE29-580C-483E-A5C9-ED8714DD085CQ30357425-079C83DF-8634-4224-BB47-4E6004607268Q30528027-FD28E53A-A6B1-4E4B-8C44-31DD96340F49Q30826339-EE91E87F-1B2D-4595-9AF1-4ADC43EFF25EQ33543381-04B0470D-E48F-48FA-BF5B-F14ADC1BD1BDQ33553429-7425555F-E17F-4DED-80D7-EBE1608DD974Q33594133-60551245-32E2-4F30-A1C7-E3312D19A9DDQ33628048-162E386B-FAD8-416C-96AA-6AB4CDED66E1Q34020000-A324B956-2C66-4BB8-B03C-92B23A6A1FFFQ34193337-A127C58A-43AC-46AF-B9C5-53425BCF35AFQ34359099-302290CA-7F26-4CE1-87A7-207D29A32016Q34552287-4D993D2A-A09A-4729-9A03-002DB1E51C47Q34677113-5DE70ADA-E0F1-40B3-96EA-EF30C0C81CD7Q34998572-1294EA42-CBB4-4486-B139-854B57C7FE4BQ35041925-718CF34D-DB50-453F-BA1C-84680A1C343DQ35048581-CC20F749-1771-487C-B810-D6A086F4BE89Q35135708-84A94EF0-4EC2-46EE-A535-299C8D5FD1B2Q35146896-BEE7B53E-8167-4D67-B76F-C4CFB5A09590Q35568177-FCECA2FF-53FE-4A2F-B940-7583CAFEF0B5Q35594507-6A00F578-01B7-4578-AC47-EA115EADE455Q35669877-586E9C97-2E9A-4509-BA73-6FE518D9B1ACQ35687287-5C8AA484-BA4D-45F7-89A4-FFDFDDD68123Q35713134-183A897F-0979-4612-8F5E-551987F35D26Q35802078-6E43EBFD-990F-429A-B818-5FE36207ED42Q35866744-6DF41D2B-661E-4D41-898F-78B65EDD1CAF
P2860
Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease – is this type 3 diabetes?
description
im März 2005 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 2005
@uk
name
Impaired insulin and insulin-l ...... ase – is this type 3 diabetes?
@en
Impaired insulin and insulin-l ...... ase – is this type 3 diabetes?
@nl
type
label
Impaired insulin and insulin-l ...... ase – is this type 3 diabetes?
@en
Impaired insulin and insulin-l ...... ase – is this type 3 diabetes?
@nl
prefLabel
Impaired insulin and insulin-l ...... ase – is this type 3 diabetes?
@en
Impaired insulin and insulin-l ...... ase – is this type 3 diabetes?
@nl
P2093
P356
P1476
Impaired insulin and insulin-l ...... ase – is this type 3 diabetes?
@en
P2093
Benjamin M. Terry
Enrique J. Rivera
Eric Steen
Jack R. Wands
Jennifer L. Cannon
Rose Tavares
Suzanne M. de la Monte
Thomas R. Neely
X. Julia Xu
P356
10.3233/JAD-2005-7107
P577
2005-03-03T00:00:00Z